대한부인종양학회

최신 논문

총 게시글 : 50

Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium 2026-09-30 VIEW : 1
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK 2026-09-30 VIEW : 1
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer 2026-09-30 VIEW : 1
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer 2026-09-30 VIEW : 2
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249 2026-09-30 VIEW : 1
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial 2026-06-24 VIEW : 2
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II 2026-06-24 VIEW : 6
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I 2026-06-24 VIEW : 7
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trial. 2026-06-24 VIEW : 6
Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial 2026-06-24 VIEW : 2
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial 2026-06-24 VIEW : 4
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial 2026-03-17 VIEW : 3
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial 2026-03-17 VIEW : 2
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial 2026-03-17 VIEW : 3
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trial. 2026-03-17 VIEW : 5

1
2
3
4